Trial · NCT04250207
Results by group231
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 231
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Central Corneal Endothelial Cell Density (ECD) at Week 12 | K-321 QID | 530.86 | Standard Deviation 312.453 | cells/mm2 | |
| Central Corneal Endothelial Cell Density (ECD) at Week 12 | K-321 BID | 468.02 | Standard Deviation 322.361 | cells/mm2 | |
| Central Corneal Endothelial Cell Density (ECD) at Week 12 | Placebo | 228.05 | Standard Deviation 297.860 | cells/mm2 | |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Baseline | 440.01 | Standard Deviation 774.300 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Baseline | 319.06 | Standard Deviation 593.294 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | Placebo | Baseline | 254.27 | Standard Deviation 468.027 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Week 1 | 0.00 | Standard Deviation 0.00 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Week 1 | 0.05 | Standard Deviation 0.218 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | Placebo | Week 1 | 0.05 | Standard Deviation 0.213 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Week 2 | 0.00 | Standard Deviation 0.00 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Week 2 | 0.05 | Standard Deviation 0.218 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | Placebo | Week 2 | 0.05 | Standard Deviation 0.213 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Week 3 | 131.98 | Standard Deviation 171.648 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Week 3 | 31.90 | Standard Deviation 102.749 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | Placebo | Week 3 | 27.49 | Standard Deviation 127.828 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Week 5 | 167.36 | Standard Deviation 176.049 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Week 5 | 167.94 | Standard Deviation 218.321 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | Placebo | Week 5 | 104.54 | Standard Deviation 218.264 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 QID | Week 7 | 303.14 | Standard Deviation 294.919 | cells/mm2 |
| Central Corneal ECD From Baseline to Each Subsequent Visit | K-321 BID | Week 7 | 302.95 | Standard Deviation 232.956 | cells/mm2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04250207/results